All In MedTech

FDA Clearance Tracker · K251697

Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test Strip

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Nov 26, 2025 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Nov 26, 2025

Substantially Equivalent

Time to decision

177 days

Received Jun 2, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Dual Track

Device class

Class I

The decision

FDA number
K251697
Device name
Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test Strip
Applicant location
San Diego, CA
Received
Jun 2, 2025
Decided
Nov 26, 2025
Decision
Substantially Equivalent
Submission type
Dual Track

Device type

Device class
Class I
Regulation
21 CFR 866.3740

Every decision under product code GTY

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code GTY. The earliest in FDA's data is K812808, decided Dec 30, 1981.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K251697
  • The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for ACON Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.